25-hydroxyvitamin D in obese youth across the spectrum of glucose tolerance from normal to prediabetes to type 2 diabetes

Diabetes Care

Volumn 36, Issue 7, 2013, Pages 2048-2053

  De Las Heras, Javier ^a,b   Rajakumar, Kumaravel ^b   Lee, Sojung ^b   Bacha, Fida ^b,c   Holick, Michael F ^d   Arslanian, Silva A ^b  

^a HOSPITAL DE CRUCES   (Spain)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; GLUCOSE; INSULIN; METFORMIN;

ABDOMINAL OBESITY; ADOLESCENT; ADULT; AGE; ARTICLE; BODY COMPOSITION; BODY MASS; CELL FUNCTION; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; IN VIVO STUDY; INSULIN RELEASE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; SCHOOL CHILD; SEX RATIO; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; LINEAR MODELS; MALE; OBESITY; PREDIABETIC STATE; VITAMIN D; YOUNG ADULT;

EID: 84875136409     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1288     Document Type: Article

References (30)

1. Delvin EE, Lambert M, Levy E., et al. Vitamin D status is modestly associated with glycemia and indicators of lipid metabolism in French-Canadian children and adolescents. J Nutr 2010;140:987-991
2. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and themetabolic syndrome amongU.S. adults. Diabetes Care 2005;28:1228-1230
3. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008;57: 2619-2625
4. Gulseth HL, Gjelstad IMF, Tierney AC., et al. Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome. Diabetes Care 2010;33:923-925
5. Rajakumar K, de las Heras J, Lee S, Holick MF, Arslanian SA. 25-hydroxyvitamin D concentrations and in vivo insulin sensitivity and β-cell function relative to insulin sensitivity in black and white youth. Diabetes Care 2012;35:627-633
6. Reis JP, von Mühlen D, Miller ER 3rd, Michos ED, Appel LJ. Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics 2009;124:e371-e379
7. Genuth S, Alberti KG, Bennett P., et al; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Followup report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-3167
8. Tfayli H, Bacha F, Gungor N, Arslanian S. Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients. Diabetes 2009;58:738-744
9. Bacha F, Gungor N, Lee S, Arslanian SA. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes? Diabetes Care 2009;32:100-105
10. Rajakumar K, de las Heras J, Chen TC, Lee S, Holick MF, Arslanian SA. Vitamin D status, adiposity, and lipids in black American and Caucasian children. J Clin Endocrinol Metab 2011;96:1560-1567
11. Lee S, Kuk JL, Hannon TS, Arslanian SA. Race and gender differences in the relationships between anthropometrics and abdominal fat in youth. Obesity (Silver Spring) 2008;16:1066-1071
12. Danadian K, Balasekaran G, Lewy V, Meza MP, Robertson R, Arslanian SA. Insulin sensitivity in African-American children with and without family history of type 2 diabetes. Diabetes Care 1999;22:1325-1329
13. Lee S, Guerra N, Arslanian S. Skeletal muscle lipid content and insulin sensitivity in black versus white obese adolescents: is there a race differential? J Clin Endocrinol Metab 2010;95:2426-2432
14. Burns SF, Lee S, Arslanian SA. In vivo insulin sensitivity and lipoprotein particle size and concentration in black and white children. Diabetes Care 2009;32:2087-2093
15. Tfayli H, Lee S, Arslanian S. Declining beta-cell function relative to insulin sensitivity with increasing fasting glucose levels in the nondiabetic range in children. Diabetes Care 2010;33:2024-2030
16. Bacha F, Saad R, Gungor N, Arslanian SA. Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents? Diabetes Care 2006;29:1599-1604
17. Arslanian SA, Saad R, Lewy V, Danadian K, Janosky J. Hyperinsulinemia in africanamerican children: decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity. Diabetes 2002;51:3014-3019
18. Chen TC, Turner AK, Holick MF. Methods for the determination of the circulating concentration of 25-hydroxyvitamin D. J Nutr Biochem 1990;1:315-319
19. Holick MF, Siris ES, Binkley N., et al. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005;90:3215-3224
20. Holick MF, Binkley NC, Bischoff-Ferrari HA., et al; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911-1930
21. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820-825
22. Karnchanasorn R, Ou H-Y, Chiu KC. Plasma 25-hydroxyvitamin D levels are favorably associated with β-cell function. Pancreas 2012;41:863-868
23. Grimnes G, Figenschau Y, Almås B, Jorde R. Vitamin D, insulin secretion, sensitivity, and lipids: results from a case-control study and a randomized controlled trial using hyperglycemic clamp technique. Diabetes 2011;60:2748-2757
24. Muscogiuri G, Sorice GP, Prioletta A., et al. 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring) 2010;18: 1906-1910
25. Lee S, Kim Y, Kuk JL, Boada FE, Arslanian S. Whole-Body MRI and Ethnic Differences in Adipose Tissue and Skeletal Muscle Distribution in Overweight Black and White Adolescent Boys. Journal of Obesity 2011;2011.
26. Lamendola CA, Ariel D, Feldman D, Reaven GM. Relations between obesity, insulin resistance, and 25-hydroxyvitamin D. Am J Clin Nutr 2012;95:1055-1059
27. Cheng S, Massaro JM, Fox CS., et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 2010;59:242-248
28. Li HWR, Brereton RE, Anderson RA, Wallace AM, Ho CKM. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metabolism 2011;60:1475-1481
29. Muscogiuri G, Policola C, Prioletta A., et al. Low levels of 25(OH)D and insulinresistance: 2 unrelated features or a cause-effect in PCOS? Clin Nutr 2012; 31:476-480
30. Husemoen LLN, Thuesen BH, Fenger M., et al. Serum 25(OH)D and type 2 diabetes association in a general population: a prospective study. Diabetes Care 2012;35: 1695-1700